Rontalizumab

DB12844InvestigationalProtein Based Therapies

Rontalizumab has been used in trials studying the treatment of Systemic Lupus Erythematosus.

Mechanism
Curator reviewed

Resolves to

Compound
UNIILDO2FIQ61ICAS948570-30-7
Targets
P01563IFNA2

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
382Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Rontalizumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In